squamous non selile selile kuvura kanseri y'ibihaha

Kuvura kanseri y'ibihaha idasanzwe amahitamo aratandukanye bitewe nurwego, aho biherereye, nubuzima rusange bwumurwayi. Gahunda yo kuvura irashobora kubamo kubaga, kuvura imirasire, chimiotherapie, kuvura intego, immunotherapy, cyangwa guhuza ubu buryo. Gusobanukirwa aya mahitamo no kubiganiraho neza nitsinda ryanyu ryita ku buzima ni ngombwa mu gufata ibyemezo byuzuye bijyanye no kwita kwawe. Aka gatabo gatanga incamake yimbitse yuburyo butandukanye bwo kuvura buboneka kuri NSCLC yuzuye, igamije kuguha imbaraga nubumenyi bwo kuyobora urugendo rwawe rwo kwivuza.Kwumva kanseri yibihaha itari mito mito (NSCLC)Indwara ya kanseri y'ibihaha itari ntoya (NSCLC) ni ubwoko bwa kanseri y'ibihaha ikomoka mu ngirabuzimafatizo zigaragara mu myuka. Nubwoko bwa NSCLC, nuburyo bwa kanseri yibihaha. Itandukanyirizo hagati ya NSCLC idasanzwe kandi idahwitse ningirakamaro kuko uburyo bwo kuvura burashobora gutandukana.Ibintu bishobora guteza impanuka NSCLCIbintu byinshi bishobora kongera ibyago byo gutera imbere kanseri y'ibihaha itari kanseri y'ibihaha: Kunywa itabi: Impamvu zikomeye ziterwa ningaruka. Guhura numwotsi wokunywa itabi. Guhura na asibesitosi, radon, nizindi kanseri. Amateka yumuryango wa kanseri yibihaha. squamous non-small selile kanseri y'ibihaha bigenwa nicyiciro cya kanseri, ubuzima bwumurwayi muri rusange, nibindi bintu byihariye. Ibi bishobora kubamo: Kubaga Kubaga akenshi niwo murongo wambere wokuvura hakiri kare kanseri y'ibihaha itari kanseri y'ibihaha. Intego ni ugukuraho ikibyimba na lymph node zose zanduye. Ubwoko bwo kubaga burimo: Kwanga Wedge: Kurandura agace gato, kameze nk'igiti cy'ibihaha.Lobectomy: Gukuraho igihimba cyose cy'ibihaha.Pneumonectomy: Kurandura ibihaha byose (bidakunze kubaho) .Kubaga bigira akamaro cyane iyo kanseri iba iherereye kandi ikaba idakwirakwira mu bice bya kure byumubiri.Radiation Therapy. Irashobora gukoreshwa nkubuvuzi bwibanze, cyangwa hamwe no kubaga cyangwa chimiotherapie. Ubwoko bwo kuvura imirasire burimo: Ubuvuzi bwo hanze bwumuriro (EBRT): Imirasire itangwa mumashini hanze yumubiri.Ubuvuzi bwimirasire yumubiri wa stereotactique (SBRT): Bitanga urugero rwinshi rwimirasire kumibyimba yibasiwe neza mubuvuzi buke. Ubuvuzi bwa radiasiyo burashobora kandi gukoreshwa mugukuraho ibimenyetso bya kanseri yateye imbere, nko kubabara cyangwa kubura umwuka. Kuvura kanseri y'ibihaha idasanzwe akenshi harimo imirasire.ChemotherapyChemotherapie ikoresha imiti yica kanseri ya kanseri mumubiri. Bikunze gukoreshwa mubyiciro byateye imbere bya kanseri y'ibihaha itari kanseri y'ibihaha cyangwa iyo kanseri imaze gukwirakwira mu tundi turere. Irashobora gutangwa mbere yo kubagwa (neoadjuvant), nyuma yo kubagwa (adjuvant), cyangwa nk'ubuvuzi nyamukuru bw'indwara zateye imbere. Bitandukanye na chimiotherapie, yibasira ingirabuzimafatizo zose zigabanya vuba, imiti igamije kurwanya kanseri gusa, bishobora kugabanya ingaruka. Nyamara, ubuvuzi bugamije ni bwiza gusa iyo selile yibibyimba ifite intego yihariye yibasirwa nibiyobyabwenge. Kwipimisha molekuline bikorerwa kubibyimba kugirango tumenye izo ntego. Mugihe bidakunze kugaragara muri kanseri yibihaha ya kanseri yibihaha kurusha ubundi bwoko bwa kanseri yibihaha, ubushakashatsi burakomeje.ImmunotherapyImmunotherapy ifasha sisitemu yumubiri yumubiri kurwanya kanseri. Iyi miti ikora ihagarika poroteyine zimwe na zimwe zibuza umubiri kwirinda indwara ya kanseri. Immunotherapy yerekanye amasezerano mu kuvura kanseri y'ibihaha itari kanseri y'ibihaha, cyane cyane mubyiciro byateye imbere. Imiti isanzwe ikingira indwara ikoreshwa muri NSCLC irimo pembrolizumab, nivolumab, na atezolizumab.Ikipe kuri Shandong Baofa Ikigo Cyubushakashatsi Kanseri igira uruhare runini mu bushakashatsi no gushyira mu bikorwa imiti mishya ikingira kanseri y'ibihaha. Ibigeragezo bya ClinicalIbizamini bya kliniki ni ubushakashatsi bwakozwe bugerageza uburyo bushya bwo kuvura cyangwa guhuza imiti. Abarwayi hamwe kanseri y'ibihaha itari kanseri y'ibihaha Urashobora gutekereza kwitabira ibizamini byubuvuzi kugirango ubone uburyo bwo kuvura butaraboneka henshi.Ubuvuzi bwa Stage ya Squamous NSCLCIcyiciro cya kanseri y'ibihaha itari kanseri y'ibihaha ni ikintu gikomeye muguhitamo uburyo bwiza bwo kuvura. Gutegura bifasha kumenya urugero rwa kanseri ndetse niba yarakwirakwiriye no mu bindi bice by'umubiri. Amahitamo yo kuvura aratandukanye cyane bitewe nicyiciro. Icyiciro cya I na IIIcyiciro-cyambere (I na II) squamous non-small selile kanseri y'ibihaha mubisanzwe harimo kubaga kugirango bakureho ikibyimba, hakurikiraho imiti ya chimiotherapie niba bikenewe. Imiti ivura imirasire irashobora kandi gukoreshwa, cyane cyane niba kubaga atari amahitamo. Icyiciro cya IIISA III kanseri y'ibihaha itari kanseri y'ibihaha ni byinshi kandi akenshi bisaba guhuza imiti, nko kubaga, kuvura imirasire, hamwe na chimiotherapie. Immunotherapy irashobora kandi gusuzumwa nyuma ya chemoradiation. Uburyo bwihariye buterwa nubunini bwa kanseri nubuzima bwumurwayi muri rusange. Icyiciro cya IVIcyiciro cya IV squamous non-small selile kanseri y'ibihaha yibanda ku kurwanya kanseri, kugabanya ibimenyetso, no kuzamura imibereho. Uburyo bwo kuvura bushobora kubamo chimiotherapie, kuvura intego (niba bishoboka), immunotherapie, hamwe nubuvuzi bwimirasire. Ubuvuzi bwa Palliative nabwo ni igice cyingenzi cyokuvura kugirango ukemure ububabare nibindi bimenyetso. Ingaruka zo Kuvura Buri buryo bwo kuvura kuri kanseri y'ibihaha itari kanseri y'ibihaha Birashobora kugira ingaruka. Ni ngombwa kuganira kuri izi ngaruka zishobora guterwa nitsinda ryanyu ryita ku buzima no gutegura gahunda yo kuzikoresha neza. Ingaruka zikunze kugaragara zirimo umunaniro, isesemi, guta umusatsi (hamwe na chimiotherapie), kurakara kuruhu (hamwe nimirasire), hamwe ningaruka ziterwa n’ubudahangarwa (hamwe na immunotherapie) .Palliative CarePalliative care ni ubuvuzi bwihariye bwibanda ku gutanga ibimenyetso by’indwara n’ibibazo by’indwara ikomeye. Birakwiye kumyaka iyo ari yo yose no murwego urwo arirwo rwose kanseri y'ibihaha itari kanseri y'ibihaha. Ubuvuzi bwa palliative burashobora kuzamura imibereho yumurwayi nimiryango yabo. Gukurikirana Ubuvuzi Nyuma yo kurangiza kwivuza kanseri y'ibihaha itari kanseri y'ibihaha, buri gihe gukurikirana-gahunda ni ngombwa mugukurikirana ibisubirwamo no gucunga ingaruka zose z'igihe kirekire. Iyi gahunda ishobora kuba ikubiyemo ibizamini byumubiri, ibizamini byerekana amashusho, hamwe nipimisha ryamaraso. squamous non-small selile kanseri y'ibihaha birakomeje, hamwe nubuvuzi bushya nuburyo butezwa imbere igihe cyose. Igeragezwa rya Clinical ririmo gusuzuma uburyo bushya bwo kuvura, gukingira indwara, hamwe no kuvura. Iterambere ritanga ibyiringiro kubisubizo byiza kubarwayi bafite NSCLC isebanya. Gufata ibyemezo Bimenyeshejwe Guhitamo isuzuma rya kanseri y'ibihaha itari kanseri y'ibihaha birashobora kuba byinshi. Ni ngombwa gukusanya amakuru menshi ashoboka no kuganira neza uburyo bwo kwivuza hamwe nitsinda ryanyu ryita ku buzima. Ntutindiganye kubaza ibibazo no gushaka ibisobanuro kubintu byose utumva. Gufata ibyemezo bisobanutse ningirakamaro mu kuyobora urugendo rwawe rwo kuvura.Incamake yuburyo bwo kuvura Ibisobanuro Ibisobanuro rusange Ingaruka zo Kubaga Gukuraho ikibyimba hamwe nuduce twose. Kubabara, kwandura, kuva amaraso, guhumeka neza. Imiti ivura imishwarara ikoresha imirasire yingufu nyinshi kugirango yice selile. Umunaniro, kurakara uruhu, isesemi, ingorane zo kumira. Chimoterapi Koresha imiti yica kanseri umubiri wose. Isesemi, kuruka, guta umusatsi, umunaniro, ibisebe byo mu kanwa. Ubuvuzi bugamije Kwibanda kuri molekile zihariye zigira uruhare mu mikurire ya kanseri. Biratandukanye bitewe nibiyobyabwenge; irashobora gushiramo uruhu, impiswi, umunaniro. Immunotherapy Ifasha umubiri wumubiri kurwanya kanseri. Umunaniro, kurwara uruhu, impiswi, gutwika ingingo. Inshingano: Aya makuru agamije gutanga amakuru gusa kandi ntagomba gufatwa nkinama zubuvuzi. Buri gihe ujye ubaza inzobere mu by'ubuzima zujuje ibisabwa ku buzima cyangwa mbere yo gufata ibyemezo byose bijyanye n'ubuzima bwawe cyangwa ubuvuzi.Ibipimo byamakuru mumeza yabonetse Umuryango w'Abanyamerika.